November 1, 1995The Journal of Urology
Benign Prostatic Hyperplasia Specific Health Status Measures in Clinical Research: How Much Change in the American Urological Association Symptom Index and the Benign Prostatic Hyperplasia Impact Index is Perceptible to Patients?
Authors
Discussion
Loading...
Member takes
Implication
Clinical investigation reveals patient-perceptible score thresholds in benign prostatic hyperplasia, highlighting meaningful outcome targets for clinical trials.
Key Points
- To determine the magnitude of change in the American Urological Association Symptom Index and the Benign Prostatic Hyperplasia Impact Index that is perceptible and clinically meaningful to patients.
- Assessed patient-reported responses to the American Urological Association (AUA) Symptom Index.
- Evaluated corresponding score shifts on the Benign Prostatic Hyperplasia (BPH) Impact Index in clinical research contexts.
- Identified score change thresholds in the AUA Symptom Index that correspond directly to patient-perceived improvements or worsenings in urinary health status.
- Established empirical guidance for utilizing the BPH Impact Index to interpret meaningful clinical trial outcome measures.
Cite This Study
Barry et al. (1995) studied this question.